Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,090
+1,250 (14.14%)
At close: Aug 28, 2026

KRX:019170 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-815.288,825-15,387-57,325-35,377-11,584
Depreciation & Amortization
11,31611,39311,96311,90812,80312,675
Loss (Gain) From Sale of Assets
-21.08-2.54-6.89-39.65-18.31-49.02
Asset Writedown & Restructuring Costs
----703.23-
Loss (Gain) From Sale of Investments
2,9322,820-1,2161,011-845.62-253.64
Loss (Gain) on Equity Investments
---6,514697.09-2,620
Provision & Write-off of Bad Debts
-86.72-982.49-86.422,9391,395-937.06
Other Operating Activities
2,6415,290-588.59,8346,692-58,525
Change in Accounts Receivable
-680.16-1,1213,0905,805-1,2258,199
Change in Inventory
-1,672-3,628-942.29-7,049972.411,774
Change in Accounts Payable
-2,064-2,720209.57-2,295-435.913,385
Change in Other Net Operating Assets
6,019-2,620-12,1903,890-11,806-23,093
Operating Cash Flow
17,56917,254-15,155-24,808-26,444-71,028
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,995-3,477-5,569-14,888-5,323-4,425
Sale of Property, Plant & Equipment
21.210.376.953.261.0116.63
Sale (Purchase) of Intangibles
-451.06-513.09-519.7-142.52-334.9-953.63
Investment in Securities
-6,732-10,7162,473-1,18248,84654,379
Other Investing Activities
009,192-1508.0111.16
Investing Cash Flow
-11,157-14,7065,583-16,30943,19749,028

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-11,88512,00045,000-10,000
Long-Term Debt Repaid
--8,180-5,843-1,761-1,869-11,262
Net Debt Issued (Repaid)
2,5243,7056,15743,239-1,869-1,262
Common Dividends Paid
------5,156
Other Financing Activities
-388.29-040-40--
Financing Cash Flow
2,1363,7056,19743,199-1,869-6,418

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,124-806.211,56127.29-830.79252.16
Miscellaneous Cash Flow Adjustments
-0-00-0-00
Net Cash Flow
9,6715,447-1,8142,10914,054-28,166

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
13,57413,776-20,724-39,696-31,767-75,453
Free Cash Flow Growth
------
Free Cash Flow Margin
5.68%5.87%-9.37%-19.82%-15.18%-39.87%
Free Cash Flow Per Share
273.98279.60-405.39-774.37-619.69-1471.90
Levered Free Cash Flow
7,2898,628-5,184-26,774-16,386-48,674
Unlevered Free Cash Flow
9,18610,308-3,539-25,700-16,348-48,548

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2,3142,6072,5661,6472.06158.16
Cash Income Tax Paid
633.4-317.293,312-2,962-554.2565,648
Change in Working Capital
1,602-10,089-9,832350.99-12,494-9,735